iHuman (IH) Cash & Equivalents (2019 - 2026)

iHuman (IH) has reported Cash & Equivalents for 8 consecutive years, with $51.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 33469.08% year-over-year to $51.7 million; the TTM figure through Mar 2026 stood at $51.7 million (up 33469.08% YoY), while the FY2025 annual figure was $164.6 million, up 6.96% from the prior year.
• Cash & Equivalents eased to $51.7 million in Q1 2026 per IH's latest filing, from $162.3 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $72.5 billion in Q3 2025 and bottomed at $83661.7 in Q2 2025.
• Historically, Cash & Equivalents has averaged $5.7 billion across 5 years, with a median of $123.4 million in 2024.
• Annual changes were most pronounced in 2025 — Cash & Equivalents tumbled 99.93% — and 2026, when it soared 33469.08%.
• iHuman's Cash & Equivalents stood at $147.6 million in 2022, then advanced by 14.19% to $168.6 million in 2023, then retreated by 7.24% to $156.4 million in 2024, then climbed by 3.79% to $162.3 million in 2025, then slumped by 68.16% to $51.7 million in 2026.
• Business Quant data shows IH's Cash & Equivalents at $51.7 million in Q1 2026, $162.3 million in Q4 2025, and $72.5 billion in Q3 2025.